Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Eli Lilly and Company
Seagen Inc.
Novartis
Varian, a Siemens Healthineers Company
City of Hope Medical Center
University Health Network, Toronto
Jonsson Comprehensive Cancer Center
Compugen Ltd
Tempus AI
N.N. Petrov National Medical Research Center of Oncology
Memorial Sloan Kettering Cancer Center
Checkpoint Therapeutics, Inc.
NextCure, Inc.
Revolution Medicines, Inc.
Baltimore VA Medical Center
Comprehensive Support Project for Oncology Research